Φορτώνει......
Updates on Oncolytic Virus Immunotherapy for Cancers
The 2018 annual Cambridge Healthtech Institute’s International Immuno-Oncology Summit in Boston, MA convened late August, and academic and industry researchers were allowed to debate and discuss oncolytic virology during the virus immunotherapy portion of the conference. The breakthrough agent, TVEC...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Mol Ther Oncolytics |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
American Society of Gene & Cell Therapy
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7536361/ https://ncbi.nlm.nih.gov/pubmed/33072862 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2019.01.008 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|